Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation
AbstractBackgroundThe longstanding association between the major histocompatibility complex (MHC) locus and schizophrenia (SZ) risk has recently been accounted for, partially, by structural variation at the complement component 4 (C4) gene. This structural variation generates varying levels ofC4RNA expression, and genetic information from the MHC region can now be used to predictC4RNA expression in the brain. Increased predictedC4ARNA expression is associated with the risk of SZ, andC4is reported to influence synaptic pruning in animal models.MethodsBased on our previous studies associating MHC SZ risk variants with poorer memory performance, we tested whether increased predictedC4ARNA expression was associated with reduced memory function in a large (n= 1238) dataset of psychosis cases and healthy participants, and with altered task-dependent cortical activation in a subset of these samples.ResultsWe observed that increased predictedC4ARNA expression predicted poorer performance on measures of memory recall (p= 0.016, corrected). Furthermore, in healthy participants, we found that increased predictedC4ARNA expression was associated with a pattern of reduced cortical activity in middle temporal cortex during a measure of visual processing (p< 0.05, corrected).ConclusionsThese data suggest that the effects ofC4on cognition were observable at both a cortical and behavioural level, and may represent one mechanism by which illness risk is mediated. As such, deficits in learning and memory may represent a therapeutic target for new molecular developments aimed at alteringC4’s developmental role.